Masayuki Amagai (Tokyo, Japan)
Masayuki Amagai, M.D., Ph.D. has been Professor and Chair, Department of Dermatology, Keio University School of Medicine since 2005, and Deputy Director, Keio University Hospital from 2007 to 2013, and Vice, Dean, Keio University School of Medicine since 2013.
He has also been Team Leader, Laboratory for Skin Homeostasis, RIKEN Center for Integrative Medical Sciences since 2013. He graduated Keio University School of Medicine in 1985, and completed his Ph.D. course at Keio University, Graduate School of Medicine in 1989. From 1989 to 1992, he did a postdoctoral fellowship at Dermatology Branch, NCI, NIH with guidance of Dr. John R. Stanley. Dr. Amagai has served professional societies in leadership positions including as President of Japanese Society for Investigative Dermatology (2012-14), and Vise President of Japanese Dermatological Association (2016- ).
He has also been serving a number of international journals, including as Consulting Editor for the Journal of Clinical Investigation (2007- ), Section Editor for Journal of Investigative Dermatology (2002- ), and Editorial Advisory Board for British Journal of Dermatology (2001-). He has received many honors and awards, including Alfred Marchionini Award (2002), William Montagna Lectureship Award (2003), JSPS (Japan Society for the Promotion of Science) Prize (2006), JSI (Japanese Society for Immunology) Award (2006), and Erwin von Bälz Prize (2012).
Timothy Johnson (United States of America)
Dr. Tim Johnson is the Lewis and Lillian Becker Professor at the University of Michigan. He received his medical degree and dermatology residency training at the University of Texas at Houston. After completing fellowship training in cutaneous surgery and oncology at both the University of Michigan and University of Oregon, he joined the Michigan faculty in 1990 with appointments in Dermatology, Otolaryngology and Surgery. He has served as clinical director of the Comprehensive Cancer Center Multidisciplinary Melanoma and Cutaneous Oncology Programs since 1990.
He has received many clinical, teaching, and research honors; delivered numerous national and international keynote and named lectureships over the last two decades; and is a benchmark for clinical care. He served on the board of directors and executive committees of several national and international organizations that impact dermatology, melanoma and non-melanoma skin cancer. He was an invited founding member of the National Comprehensive Cancer Network Guideline Committees for Skin Cancer and serves on the American Joint Committee on Cancer Staging.
He is an investigator on grants, clinical trials, and numerous research activities. He established robust tissue banks in non-melanoma and melanoma with linkable comprehensive clinical databases. His research is focused on integration of data and specimens with experimental models to identify molecular mechanisms of disease; as well as development of evidence-based strategies for better treatment. His publication portfolio includes over 230 original peer-reviewed publications and over 50 invited/other publications/chapters published in mainstream dermatology, surgery, and oncology journals; including top impact journals such as Nature, Nature Medicine, Journal of Clinical Oncology, Cancer Research, Nature Cell Biology, and JAMA. Dr. Johnson practices medicine exclusively at the University of Michigan, where he is an internationally acclaimed leader in dermatology; and more specifically, cutaneous oncology.
Stephen Katz (Bethesda, United States of America)
Dr. Katz has been Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases since August 1995 and is also an Adjunct Investigator in the Dermatology Branch of the National Cancer Institute. Dr. Katz has focused his studies on immunology and the skin.
His research has demonstrated that skin is an important component of the immune system both in its normal function and as a target in immunologically-mediated disease. In addition to studying Langerhans cells and epidermal-derived cytokines, Dr. Katz and his colleagues have added considerable new knowledge about inherited and acquired blistering skin diseases. Dr. Katz has trained a large number of outstanding immune-dermatologists in the U.S., Japan, Korea, and Europe. He has also served many professional societies in leadership positions and has received many honours and awards, including Honorary Membership to the EADV.
Thomas Quinn (Baltimore, United States of America)
Dr. Thomas Quinn is Distinguished Investigator and Head of the Section on International HIV/AIDS Research in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases. He is also Associate Director for International Research for the Division of Intramural Research at NIAID. In addition he is Professor of Medicine and Pathology in the Johns Hopkins School of Medicine and Professor of International Health, Epidemiology, and Immunology and Molecular Microbiology in The Johns Hopkins School of Public Health.
In 2006 he was appointed founding Director of the Johns Hopkins Center for Global Health. His research interests have involved laboratory and field investigations that have helped define the biological factors involved in sexual and perinatal transmission of HIV, the natural history and treatment of HIV infections, and the molecular epidemiology of HIV. He is a member of the National Academy of Medicine and Fellow of the American Association for the Advancement of Science. He is an author of over 1000 publications on HIV, STDs, and infectious diseases.
Caroline Robert (Villejuif, France)
She trained at the Paris V University, France, and completed a research fellowship at Harvard, Brigham & Women’s Hospital in Cancer Immunology and Immunotherapy. She chairs the Melanoma group of the European Organisation for the Research and Treatment of Cancer (EORTC) and is board member for the European Association of Onco-Dermatology (EADO), the European Society of Medical Oncology (ESMO), the European Association of Dermato-Venereology (EADV) the French society of Dermatology and Venereology (SFD), the American Society of Oncology (ASCO) and the American Association of Clinical Research (AACR).
Her main focuses of interest are clinical and translational Research on Melanoma: immunotherapy and targeted therapy, as well as the study of the cutaneous adverse events of anticancer agents. She is national and international coordinator of many clinical trials of targeted therapy and immunotherapy for melanoma patients, from phase I to III. She has authored more than 120 articles in peer-reviewed scientific journals, including a number of publications on new treatments for metastatic melanoma. Her recent work has focused on identification of new biomarkers for immunotherapy and targeted therapies of patients with melanoma.
Martin Steinhoff (Dublin, Ireland)
Prof. Martin Steinhoff is an established physician scientist with a long-standing background as a basic scientist studying mediators, pathways and their receptors that cause inflammation, autoimmune disease or cancer of the skin on a molecular level. He also uses in vivo and ex vivo models to study proof-of-principle concepts, and translates them into the human disease setting by performing human studies or clinical trials.
Prof. Steinhoff performs and teaches sclerotherapy and foam-sclerotherapy for the treatment or prevention of ulcers. He has run university consultative clinics for general dermatology, itch/eczema, psoriasis, rosacea/acne, wound ambulance for in-bed patients, day care patients and outpatients in Germany, USA and Ireland for more than 20 years. Prof. Steinhoff started his current position as Professorial Chair of the Dept. of Dermatology and as Director of the UCD Charles Institute in January 2014.
His current research interests span Systems Medicine and cell signaling, molecular neuroscience, neuroimmunology, genomics, proteomics, biomarkers, new therapies. Prof. Steinhoff received several prestigious scientific awards for his research in Germany, USA and Ireland. To date, his group has published over 300 articles, reviews and book chapters spanning basic science as well as clinical dermatology (IF: 963,527; H-index 52). He holds 11 patents, has been consultant for >25 companies, and serves on several scientific advisory boards.
Georg Stingl (Vienna, Austria)
Dr. Stingl has contributed greatly to our understanding of the skin as an immune organ under physiologic and pathologic (e.g. psoriasis, atopic dermatitis, syphilis, HIV-infection) conditions. His major accomplishments include the discovery of Langerhans cells as immunocytes and of the indigenous T-cell population of rodent skin.
In the recent years, his research group has elucidated important pathomechanisms operative in inflammatory skin diseases as well as the mode of action of several immunomodulatory drugs. He is a member of the board of several scientific societies and organisations, advisory panels, scientific journals and committees, including honorary membership of the two leading societies of dermatological research, i.e. The Society for Investigative Dermatology and the European Society for Dermatological Research. He was recently elected a Foreign Associate of the National Academy of Medicine and holds a membership in the Austrian and German National Academy of Sciences.
Alfred Vendl (Vienna, Austria)
Science and Research: Studies of Material Science at Technical University of Vienna, PhD, Research Scientist at: Imperial College/University of London, England, University Freiburg im
Breisgau, Germany, University of California – San Diego La Jolla, USA , Max-Planck-Institut of Metal-Research Stuttgart, Germany.
Since 1981 Full Professor at University of Applied Arts Vienna, head of the Institute of Art and Technology, Associative Professor at Technical University Vienna.
Around 80 scientific publications in Material Science, Archaeometry and Art Technology.
Film and Television: Education as Cameraman in Vienna, Freelance Cameraman since 1968, since 1970 work for ORF (Austrian Television) as cameraman, writer, director, producer and host of scientific talk-shows. Writer, director and/or producer of more than 200 prime-time documentaries for ORF, ARD, ZDF, WDR, BR, ARTE, BBC, Discovery, Smithsonian, WNET, etc. Many international TV-Awards among them Emmy-Award 2008 for “Nature Tech”.
Distinguished US scientist, Dr. Steve Katz (US) will open the Congress with a captivating lecture on “Dermatology 2016: If past is prologue”, followed by a spectacular movie, “Extracts from Planet You”, from the EMMY award winner Prof. Alfred Vendl (AT), projecting the fascinating micro-life in and on our skin.
Other leading expert plenary lecturers include Prof. Martine Bagot (FR) with her talk on “New therapeutic perspectives in CTCL”, a stimulating lecture on “Skin barrier homeostasis and its failure in atopic dermatitis” from Dr. Masayuki Amagai (JP), Dr. Tim Johnson (US) focusing on “Melanoma sentinal mode biopsy: Past, present and future in the new era of systemic therapies”, Prof. Tom Quinn (US) tackling “The new threats of HIV and STIs” and Dr. Caroline Robert (FR) giving her expert views on “The advancing field of melanoma immunotherapy”. The programme will also include the René Touraine Foundation guest speaker, Prof. Martin Steinhoff (IE) providing the latest on “Neuroinflammation: Contradiction or reality?” as well as ESDR Plenary Lecturer Prof. Georg Stingl (AT) speaking on “Langerhans cells in health and disease”.